Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[The population affected by neovascular age-related macular degeneration and treated with anti-Vegf through Italian administrative healthcare data.].
Calabria S, Ronconi G, Dondi L, Piccinni C, Pedrini A, Dondi L, Dell'Anno I, Esposito I, Addesi A, Staurenghi G, Bandello F, Ricci F, Martini N. Calabria S, et al. Among authors: staurenghi g. Recenti Prog Med. 2023 Jul-Aug;114(7):447-461. doi: 10.1701/4062.40464. Recenti Prog Med. 2023. PMID: 37392108 Italian.
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey.
Veritti D, Sarao V, Chhablani J, Loewenstein A, Lanzetta P; Società Italiana della Retina (SIR) Study Group; Intravitreal Injection Setting Study Group (I2SG). Veritti D, et al. Graefes Arch Clin Exp Ophthalmol. 2023 Nov;261(11):3299-3306. doi: 10.1007/s00417-023-06108-y. Epub 2023 May 18. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 37199802 Free PMC article. Review.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Among authors: staurenghi g. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Among authors: staurenghi g. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Retest variability and patient reliability indices of quantitative fundus autofluorescence in age-related macular degeneration: a MACUSTAR study report.
von der Emde L, Mallwitz M, Vaisband M, Hasenauer J, Saßmannshausen M, Terheyden JH; MACUSTAR Consortium; Sloan KR, Schmitz-Valckenberg S, Finger RP, Holz FG, Ach T. von der Emde L, et al. Sci Rep. 2023 Oct 13;13(1):17417. doi: 10.1038/s41598-023-43417-y. Sci Rep. 2023. PMID: 37833348 Free PMC article.
Author Correction: Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report.
Garzone D, Terheyden JH, Morelle O, Wintergerst MWM, Saßmannshausen M, Schmitz-Valckenberg S, Pfau M, Thiele S, Poor S, Leal S, Holz FG, Finger RP; MACUSTAR Consortium. Garzone D, et al. Sci Rep. 2023 Mar 7;13(1):3795. doi: 10.1038/s41598-023-30360-1. Sci Rep. 2023. PMID: 36882430 Free PMC article. No abstract available.
Retraction Note: Autoantibodies detection in patients affected by autoimmune retinopathies.
Ceccarini MR, Medori MC, Dhuli K, Tezzele S, Bonetti G, Micheletti C, Maltese PE, Cecchin S, Donato K, Colombo L, Rossetti L, Staurenghi G, Salvetti AP, Oldani M, Ziccardi L, Marangoni D, Iarossi G, Falsini B, Placidi G, D'Esposito F, Viola F, Nassisi M, Leone G, Cimino L, De Simone L, Mastrofilippo V, Beccari T, Bertelli M. Ceccarini MR, et al. Among authors: staurenghi g. Eur Rev Med Pharmacol Sci. 2024 May;28(9):3293. doi: 10.26355/eurrev_202405_36203. Eur Rev Med Pharmacol Sci. 2024. PMID: 38766784 Free article.
Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice.
Testa F, Bacci G, Falsini B, Iarossi G, Melillo P, Mucciolo DP, Murro V, Salvetti AP, Sodi A, Staurenghi G, Simonelli F. Testa F, et al. Among authors: staurenghi g. Eye (Lond). 2024 Apr 16. doi: 10.1038/s41433-024-03065-6. Online ahead of print. Eye (Lond). 2024. PMID: 38627549 Review.
323 results